Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sebelius Pledges To “Aggressively” Negotiate Part D Drug Prices If Given The Authority

This article was originally published in The Pink Sheet Daily

Executive Summary

HHS Secretary-designate Kathleen Sebelius tells the Senate Finance Committee she is looking forward, if able, to negotiating on behalf of Medicare Part D prescription drug plan beneficiaries.

You may also be interested in...



Sebelius Draws Parallels Between Her State Experience And HHS Tasks Ahead

Over the course of two non-contentious hearings to discuss her nomination as HHS secretary, Kansas governor Kathleen Sebelius drew many comparisons between some of the tasks envisioned through health care reform and her work at the state level

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069302

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel